Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genome-wide association study of developmental dysplasia of the hip identifies an association with GDF5.
Hatzikotoulas K, Roposch A; DDH Case Control Consortium; Shah KM, Clark MJ, Bratherton S, Limbani V, Steinberg J, Zengini E, Warsame K, Ratnayake M, Tselepi M, Schwartzentruber J, Loughlin J, Eastwood DM, Zeggini E, Wilkinson JM. Hatzikotoulas K, et al. Among authors: bratherton s. Commun Biol. 2018 May 31;1:56. doi: 10.1038/s42003-018-0052-4. eCollection 2018. Commun Biol. 2018. PMID: 30273415 Free PMC article.
Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study.
Condurache CI, Chiu S, Chotiyarnwong P, Johansson H, Shepstone L, Lenaghan E, Cooper C, Clarke S, Khioe RFS, Fordham R, Gittoes N, Harvey I, Harvey NC, Heawood A, Holland R, Howe A, Kanis JA, Marshall T, O'Neill TW, Peters TJ, Redmond NM, Torgerson D, Turner D, McCloskey E; SCOOP Study Team. Condurache CI, et al. Osteoporos Int. 2020 Mar;31(3):457-464. doi: 10.1007/s00198-019-05270-6. Epub 2020 Jan 20. Osteoporos Int. 2020. PMID: 31960099
Systematic screening using FRAX® leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial.
Parsons CM, Harvey N, Shepstone L, Kanis JA, Lenaghan E, Clarke S, Fordham R, Gittoes N, Harvey I, Holland R, Redmond NM, Howe A, Marshall T, Peters TJ, Torgerson D, O'Neill TW, McCloskey E, Cooper C; SCOOP Trial Group. Parsons CM, et al. Osteoporos Int. 2020 Jan;31(1):67-75. doi: 10.1007/s00198-019-05142-z. Epub 2019 Oct 12. Osteoporos Int. 2020. PMID: 31606826 Free PMC article. Clinical Trial.
Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study.
Söreskog E, Borgström F, Shepstone L, Clarke S, Cooper C, Harvey I, Harvey NC, Howe A, Johansson H, Marshall T, O'Neill TW, Peters TJ, Redmond NM, Turner D, Holland R, McCloskey E, Kanis JA; SCOOP study team. Söreskog E, et al. Osteoporos Int. 2020 Aug;31(8):1499-1506. doi: 10.1007/s00198-020-05372-6. Epub 2020 Apr 1. Osteoporos Int. 2020. PMID: 32239237 Free PMC article. Clinical Trial.
Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial.
Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A, Holland R, Howe A, Kanis J, Marshall T, O'Neill T, Peters T, Redmond N, Torgerson D, Turner D, McCloskey E; SCOOP Study Team. Shepstone L, et al. Lancet. 2018 Feb 24;391(10122):741-747. doi: 10.1016/S0140-6736(17)32640-5. Epub 2017 Dec 16. Lancet. 2018. PMID: 29254858 Free article. Clinical Trial.